Kim Orchard

5.5k total citations
71 papers, 1.4k citations indexed

About

Kim Orchard is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Kim Orchard has authored 71 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 23 papers in Oncology and 20 papers in Immunology. Recurrent topics in Kim Orchard's work include Hematopoietic Stem Cell Transplantation (17 papers), Acute Myeloid Leukemia Research (12 papers) and Multiple Myeloma Research and Treatments (11 papers). Kim Orchard is often cited by papers focused on Hematopoietic Stem Cell Transplantation (17 papers), Acute Myeloid Leukemia Research (12 papers) and Multiple Myeloma Research and Treatments (11 papers). Kim Orchard collaborates with scholars based in United Kingdom, United States and Switzerland. Kim Orchard's co-authors include Gillian May, Christine J. Harrison, John M. Goldman, Nicholas C.P. Cross, K. H. Th'ng, Laura Chiecchio, Gian Paolo Dagrada, R.K.M. Protheroe, Kan Luk Cheung and F. M. Ross and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

Kim Orchard

69 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim Orchard United Kingdom 23 698 583 401 247 225 71 1.4k
Peter Johnson United Kingdom 18 720 1.0× 358 0.6× 321 0.8× 151 0.6× 235 1.0× 44 1.2k
Marcel P. Devetten United States 20 704 1.0× 433 0.7× 263 0.7× 288 1.2× 594 2.6× 45 1.5k
Yongmin Tang China 16 393 0.6× 374 0.6× 408 1.0× 323 1.3× 96 0.4× 110 1.3k
Shinsuke Takagi Japan 17 808 1.2× 352 0.6× 447 1.1× 397 1.6× 207 0.9× 71 1.3k
Julián Sevilla Spain 26 1.2k 1.7× 528 0.9× 485 1.2× 640 2.6× 295 1.3× 130 2.3k
Válerie de Haas Netherlands 28 1.4k 2.0× 868 1.5× 428 1.1× 230 0.9× 297 1.3× 99 2.5k
Fei Li China 21 648 0.9× 546 0.9× 269 0.7× 344 1.4× 138 0.6× 146 1.5k
Fraia Melchionda Italy 27 256 0.4× 769 1.3× 435 1.1× 552 2.2× 164 0.7× 59 2.0k
T. Klingebiel Germany 21 599 0.9× 428 0.7× 467 1.2× 249 1.0× 185 0.8× 62 1.9k
Taiichi Kyo Japan 24 855 1.2× 549 0.9× 256 0.6× 185 0.7× 368 1.6× 64 1.6k

Countries citing papers authored by Kim Orchard

Since Specialization
Citations

This map shows the geographic impact of Kim Orchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Orchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Orchard more than expected).

Fields of papers citing papers by Kim Orchard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Orchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Orchard. The network helps show where Kim Orchard may publish in the future.

Co-authorship network of co-authors of Kim Orchard

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Orchard. A scholar is included among the top collaborators of Kim Orchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Orchard. Kim Orchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Orchard, Kim, Matthew Guy, Sofia Michopoulou, et al.. (2024). Efficient bone marrow irradiation and low uptake by non-haematological organs with an yttrium-90-anti-CD66 antibody prior to haematopoietic stem cell transplantation. Bone Marrow Transplantation. 59(9). 1247–1257. 4 indexed citations
2.
3.
Eyre, Toby A., Sally F. Barrington, Jessica Okosun, et al.. (2022). Impact of positron emission tomography - computed tomography status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplantation. Haematologica. 108(3). 785–796. 3 indexed citations
4.
Snowden, John A., Eoin McGrath, Kim Orchard, et al.. (2021). Visions for a JACIE Quality Management System 4.0. Bone Marrow Transplantation. 56(12). 2876–2881. 3 indexed citations
5.
Boullosa, Laurie Freire, Viggo Van Tendeloo, Evelien Smits, et al.. (2020). New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia. Cancer Immunology Immunotherapy. 69(5). 867–877. 3 indexed citations
6.
Bonney, Stephanie A., et al.. (2020). Serum profiling identifies ibrutinib as a treatment option for young adults with B‐cell acute lymphoblastic leukaemia. British Journal of Haematology. 189(3). 500–512. 4 indexed citations
7.
Schlüter, Daniela K, Carolyn Young, R. J. Mills, et al.. (2018). Use of coping strategies in multiple sclerosis: Association with demographic and disease-related characteristics✰. Multiple Sclerosis and Related Disorders. 27. 214–222. 27 indexed citations
8.
Snowden, John A., Eoin McGrath, Rafael F. Duarte, et al.. (2017). JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement. Bone Marrow Transplantation. 52(10). 1367–1371. 34 indexed citations
9.
McCann, Katy J., Lindsey Chudley, Ann Mander, et al.. (2015). Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study. Cancer Immunology Immunotherapy. 64(8). 1021–1032. 25 indexed citations
10.
Schmitt, Michael, Kim Orchard, Matthias Görlach, et al.. (2014). Biosimilar G-CSF Based Mobilization of Peripheral Blood Hematopoietic Stem Cells for Autologous and Allogeneic Stem Cell Transplantation. Theranostics. 4(3). 280–289. 41 indexed citations
11.
Eyre, Toby A., Emanuela Pelosi, Stephen McQuaid, et al.. (2013). Mumps virus encephalomyelitis in a 19-year old male patient with an undefined severe combined immunodeficiency post-haematopoietic bone marrow transplantation: A rare fatal complication. Journal of Clinical Virology. 57(2). 165–168. 2 indexed citations
12.
Smits, Evelien, Cindy Lee, Nicola Hardwick, et al.. (2011). Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia. Cancer Immunology Immunotherapy. 60(6). 757–769. 22 indexed citations
13.
Cook, Gordon, Graeme Smith, Keiren Kirkland, et al.. (2010). Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for Relapsed and Refractory Mantle Cell Lymphoma (MCL): A Study of the British Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 16(10). 1419–1427. 69 indexed citations
14.
Chiecchio, Laura, Gian Paolo Dagrada, Ashraf Ibrahim, et al.. (2009). Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context. Haematologica. 94(12). 1708–1713. 55 indexed citations
15.
Chiecchio, Laura, Gian Paolo Dagrada, R.K.M. Protheroe, et al.. (2009). Loss of 1p and rearrangement of MYC are associated with progression of smouldering myeloma to myeloma: sequential analysis of a single case. Haematologica. 94(7). 1024–1028. 41 indexed citations
16.
Chiecchio, Laura, Gian Paolo Dagrada, Helen E. White, et al.. (2009). Frequent upregulation of MYC in plasma cell leukemia. Genes Chromosomes and Cancer. 48(7). 624–636. 45 indexed citations
17.
Chiecchio, Laura, R.K.M. Protheroe, Ashraf Ibrahim, et al.. (2006). Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. Leukemia. 20(9). 1610–1617. 104 indexed citations
18.
Harrison, Christine J., Fiona M. Ross, Kan Luk Cheung, et al.. (2002). Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis. British Journal of Haematology. 117(2). 427–435. 47 indexed citations
19.
Orchard, Kim, et al.. (2001). Novel approaches to transplant conditioning. Hematological Oncology. 19(2). 43–57. 2 indexed citations
20.
Chase, Andrew, Kim Orchard, A. E. Watmore, et al.. (1998). Two cases of inv(8)(p11q13) in AML with erythrophagocytosis: a new cytogenetic variant. British Journal of Haematology. 100(3). 561–563. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Johnson Breakdown of academic impact, for papers by Marcel P. Devetten Breakdown of academic impact, for papers by Yongmin Tang Breakdown of academic impact, for papers by Shinsuke Takagi Breakdown of academic impact, for papers by Julián Sevilla Breakdown of academic impact, for papers by Válerie de Haas Breakdown of academic impact, for papers by Fei Li Breakdown of academic impact, for papers by Fraia Melchionda Breakdown of academic impact, for papers by T. Klingebiel Breakdown of academic impact, for papers by Taiichi Kyo
Rankless by CCL
2026